Abstract
Community-acquired bacterial meningitis (CABM) is a life-threatening infection that can be complicated by neurological deficits among survivors. These outcomes have prompted interventions in prevention and treatment. These include an ever-expanding list of vaccines and adjunctive therapy, including early corticosteroid administration. Researchers conducted a prospective cohort study in the Netherlands to provide a contemporary evaluation of the disease's incidence, clinical aspects, and management. Adult (aged …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
